BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Triple Negative Breast Cancer|HER2+ Breast Cancer|Hormone Receptor Negative Breast Cancer|Metastatic Breast Cancer
Interventions: BIOLOGICAL: Brachyury-TRICOM|DRUG: Entinostat|BIOLOGICAL: M7824|BIOLOGICAL: Ado-trastuzumab emtansine
Sponsor: National Cancer Institute (NCI)